CCR6 and cancer: CCL20, the only known ligand for the receptor CCR6, not only influences cancer progression but also participates in TME reprogramming by controlling immune cells.18 We used a Transwell assay to explore the relationship between macrophage infiltration and F. nucleatum-induced CCL20 expression in vitro.